Tag: #Global Trends

German pharmaceutical giant Boehringer Ingelheim has entered into a licensing agreement with China's Simcere Pharmaceutical Group to develop an experimental... Read more

At the 2026 J.P. Morgan Healthcare Conference, Novo Nordisk signaled its dominance with its largest-ever presence, conducting over 200 partner... Read more

n January 27, 2026, Neurocrine Biosciences announced the commencement of a Phase II clinical trial for NBI-1065890. This investigational compound... Read more

On January 27, 2026, the pharmaceutical innovation hub BioMed X announced a strategic partnership with the Government of Barbados to... Read more

On January 27, 2026, ICON plc, a global leader in clinical research, officially inaugurated the Brian Moran Cancer Institute at... Read more

On January 27, 2026, Integrated Biosciences, a Redwood City-based biotechnology firm, announced the appointment of Daniel J. Anderson, PhD, as... Read more

A recent strategic report by KPMG highlights a significant shift in technological priorities among life sciences executives. The Internet of... Read more

According to the latest update from the World Health Organization (WHO) European Regional Verification Commission, the United Kingdom, alongside Armenia,... Read more

The pharmaceutical company Roche has released positive topline data from its Phase II clinical trial (CT388-103) evaluating CT-388, an investigational... Read more